Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More
Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker has made diversification a key part ...
Cancer is well represented in the Astellas Pharma portfolio and pipeline, but the drugmaker has made diversification a key part ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
LONDON — Roche executives on Monday argued that their experimental obesity medications would prove to have advantages over their rivals’ ...
Repare Therapeutics has three cancer drug candidates in the clinic and another one expected to enter Phase 1 by the ...
Sage Therapeutics said Wednesday that an experimental pill failed to quell involuntary muscle shaking in patients with a neurological condition ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.